Specific genetic events, such as alterations in the B-catenin/WNT pathway and loss of PTEN, may also impair intra-tumoral infiltration of functional antigen presenting cells, thereby diminishing the anti-tumour immune response [49]. The gene discussed is PTEN; the disease is neoplasm.